Ensign Peak Advisors, Inc
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in ARQT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$29,317,757
-$25,927,648 QoQ
Shares Held
1,244,387
-34.6% QoQ
Ownership
0.995%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,687 across 116 Biotechnology names. ARQT ranks #11 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in ARQT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,317,757 | 1,244,387 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $55,245,405 | 1,902,390 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $37,569,086 | 1,993,055 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $28,060,174 | 2,001,439 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,098,403 | 1,988,389 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $33,071,770 | 2,374,140 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,476,351 | 2,416,812 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,843,428 | 2,133,702 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $29,535,238 | 2,980,347 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,556,761 | 2,029,957 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,386,564 | 826,095 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,934,106 | 832,540 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,348,640 | 486,240 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,171,369 | 484,552 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,351,382 | 489,345 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,095,562 | 379,895 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,542,367 | 495,450 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,704,038 | 419,674 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,315,618 | 389,938 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,840,024 | 397,216 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,952,902 | 171,203 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,085,930 | 38,604 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $640,966 | 21,876 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $226,800 | 7,500 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $223,500 | 7,500 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||